BR0316977A - Uso de lipìdios anfifìlicos para a preparação de uma composição farmacêutica para a redução de metástase de tumor - Google Patents

Uso de lipìdios anfifìlicos para a preparação de uma composição farmacêutica para a redução de metástase de tumor

Info

Publication number
BR0316977A
BR0316977A BR0316977-4A BR0316977A BR0316977A BR 0316977 A BR0316977 A BR 0316977A BR 0316977 A BR0316977 A BR 0316977A BR 0316977 A BR0316977 A BR 0316977A
Authority
BR
Brazil
Prior art keywords
preparation
pharmaceutical composition
tumor metastasis
cancer
amphiphilic lipids
Prior art date
Application number
BR0316977-4A
Other languages
English (en)
Inventor
Ewald Schlotzer
Torbjoern Wornheim
Marc Jansen
Karl-Heinz Treutner
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of BR0316977A publication Critical patent/BR0316977A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"USO DE LIPìDIOS ANFIFìLICOS PARA A PREPARAçãO DE UMA COMPOSIçãO FARMACêUTICA PARA A REDUçãO DA METáSTASE DE TUMOR". A presente invenção refere-se ao uso de lipídios anfifílicos para a preparação de uma composição farmacêutica para a redução da metástase de tumor, de preferência através do tratamento profilático da recorrência intraperitoneal de tumores, de modo específico de tumores malígnos, como por exemplo, o câncer gastrointestinal, tal como o câncer gástrico, do cólon, ou do pâncreas, e o câncer do sistema geniturinário tal como o câncer de ovário e câncer da bexiga urinária.
BR0316977-4A 2002-12-03 2003-12-01 Uso de lipìdios anfifìlicos para a preparação de uma composição farmacêutica para a redução de metástase de tumor BR0316977A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026897A EP1426053A1 (en) 2002-12-03 2002-12-03 Use of amphiphilic lipids for reducing tumor metastasis
PCT/EP2003/013507 WO2004050097A1 (en) 2002-12-03 2003-12-01 Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis

Publications (1)

Publication Number Publication Date
BR0316977A true BR0316977A (pt) 2005-10-25

Family

ID=32309363

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316977-4A BR0316977A (pt) 2002-12-03 2003-12-01 Uso de lipìdios anfifìlicos para a preparação de uma composição farmacêutica para a redução de metástase de tumor

Country Status (12)

Country Link
EP (2) EP1426053A1 (pt)
KR (2) KR20110091010A (pt)
CN (1) CN1744901B (pt)
AT (1) ATE506067T1 (pt)
AU (1) AU2003289924A1 (pt)
BR (1) BR0316977A (pt)
DE (1) DE60336842D1 (pt)
ES (1) ES2365218T3 (pt)
HK (1) HK1078804A1 (pt)
MX (1) MXPA05005759A (pt)
PT (1) PT1569657E (pt)
WO (1) WO2004050097A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275435B1 (es) * 2005-11-18 2008-06-01 Farmaleis, S.L. "composicion farmaceutica que comprende escualeno y uso de la misma para la preparacion de un medicamento para el tratamiento del cancer.
PT1800675E (pt) 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
KR20190022796A (ko) * 2016-06-29 2019-03-06 마하베르트 파마수티컬스 엘엘씨 인지질 조성물들
WO2024049792A1 (en) * 2022-08-29 2024-03-07 University Of Cincinnati Immunotherapeutic phospholipids for cancer treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1188654B (it) * 1985-04-15 1988-01-20 Toyo Jozo Kk Coniugato nucleo side-fosfolipide
CA2007507C (en) * 1989-02-03 1998-05-19 Yasuyuki Igarashi Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament

Also Published As

Publication number Publication date
CN1744901A (zh) 2006-03-08
KR20050085230A (ko) 2005-08-29
ATE506067T1 (de) 2011-05-15
PT1569657E (pt) 2011-07-08
CN1744901B (zh) 2012-11-07
EP1569657A1 (en) 2005-09-07
ES2365218T3 (es) 2011-09-26
HK1078804A1 (en) 2006-03-24
KR20110091010A (ko) 2011-08-10
WO2004050097A1 (en) 2004-06-17
KR101060442B1 (ko) 2011-08-29
EP1426053A1 (en) 2004-06-09
AU2003289924A1 (en) 2004-06-23
DE60336842D1 (de) 2011-06-01
MXPA05005759A (es) 2005-08-16
EP1569657B1 (en) 2011-04-20

Similar Documents

Publication Publication Date Title
CY1116964T1 (el) Μονοκλωνικα αντισωματα εναντι claudin-18 στην αγωγη εναντι καρκινου
PH12013500123A1 (en) Hemiasterlin derivatives and uses thereof
EP1572100A4 (en) PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MODULATING ANGIOGENESIS, METASTASIS ENRICHMENT AND TUMOR FIBROSIS AND DETERMINING MALIGNANT CANCER COLON TUMORS
NO20076401L (no) Diarylhydantoinforbindelser
CY1107839T1 (el) Υδροξαμικα παραγωγα χρησιμα ως αναστολεις δεακετυλασης
WO2003050243A3 (en) Novel genes encoding colon cancer antigens
WO2006044975A3 (en) Compositions and their use as anti-tumor agents
WO2006016912A3 (en) Synthesis of (-)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, (-)-beta-elemene fluoride and their analogues, intermediates and composition and uses thereof
UA99602C2 (ru) Антитело, специфически связывающееся с jam-a, способное ингибировать пролиферацию опухолевых клеток
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
HK1078804A1 (en) Use of amphiphilic lipids for the preparation of a pharmaceutical composition for reducing tumor metastasis
BRPI0514672A (pt) polipeptìdeos de fusobacterium e métodos de uso
WO2003079982A3 (en) Gene amplification in cancer
SE0401871D0 (sv) New compositions
EA201270376A1 (ru) Антрахинондиоксимы и их применение
WO2004073375A3 (en) Podophyllotoxin derivatives as antitumor agents
WO2002047613A3 (en) Immunogenic cancer peptides and uses thereof
TNSN04198A1 (en) Pharmaceutical composition comprising arsenite for the treatment of malignancy
ATE397673T1 (de) Verstärktes krebs-gen wip1
NO20064185L (no) Pyrazolin derivater nyttige for bahandling av kreft
WO2004014949A3 (en) Gastric and colon cancer-associated antigens
WO2006070432A3 (en) Anti-tumoral immunogenic peptides and vaccine thereof
BR0214244A (pt) Uso de uma ascomicina
WO2021076033A3 (en) Desloratadine for the treatment and/or prophylaxis of cancers
WO2003018769A3 (en) Amplified gene involved in cancer

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULACAO DO ITEM 7.1 DA RPI 2211 DE 21/05/13, POR TER SIDO INDEVIDA.

B07C Technical examination (opinion): republication [chapter 7.3 patent gazette]

Free format text: REPUBLICACAO DO ITEM 7.2 DA RPI 2264 DE27/05/2014, POR TER SIDO EFETUADA COM INCORRECOES NO CODIGO DE DESPACHO, SENDO O CODIGO CORRETO O 7.4 DA RPI 2211 DE 21/05/2013.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL